-+ 0.00%
-+ 0.00%
-+ 0.00%

Mega Genomics schedules board meeting to review interim results, dividend decision

PUBT·08/03/2026 12:14:30
Listen to the news
Mega Genomics schedules board meeting to review interim results, dividend decision
  • Mega Genomics set a board meeting for Aug. 31, 2026 to review interim results for the six months ended June 30, 2026.
  • Directors will also consider an interim dividend on the same date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mega Genomics Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260803-12269543), on August 03, 2026, and is solely responsible for the information contained therein.